Cargando…
Beta-Adrenergic gene therapy for cardiovascular disease
Gene therapy using in vivo recombinant adenovirus-mediated gene transfer is an effective technique that offers great potential to improve existing drug treatments for the complex cardiovascular diseases of heart failure and vascular smooth muscle intimal hyperplasia. Cardiac-specific adenovirus-medi...
Autores principales: | Eckhart, Andrea D, Koch, Walter J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC59618/ https://www.ncbi.nlm.nih.gov/pubmed/11714426 http://dx.doi.org/10.1186/cvm-1-3-131 |
Ejemplares similares
-
Beta-adrenergic signaling, a novel target for cancer therapy?
por: Schuller, Hildegard M.
Publicado: (2010) -
At the Crossroads of Cardiac Beta-Adrenergic Receptor Signaling and Myocardial Glucose Metabolism
por: Kereliuk, Stephanie M., et al.
Publicado: (2023) -
The Beta3 Adrenergic Receptor in Healthy and Pathological Cardiovascular Tissues
por: Michel, Lauriane Y. M., et al.
Publicado: (2020) -
Beta-Adrenergic Agonists
por: Barisione, Giovanni, et al.
Publicado: (2010) -
Beta-Adrenergic Blockade in Critical Illness
por: Bruning, Rebecca, et al.
Publicado: (2021)